Australia, Sept. 18 -- Sandoz AG, owns the trademark (2625799) for 'MACURIMAB' till Feb. 9, 2036.
Status: registered:
Registered/protected
Class: 5 [pharmaceutical preparations for human use]
Type of Mark: Word
Date of Acceptance: March 16
Registration Advertised: Sept. 17
For further details contact Duncan Cotterill Lawyers.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2625799.
Disclaimer: Curated by HT Syndication.